The Pivotal Role of Advanced Echocardiography in Transcatheter Closure of Challenging Secundum Atrial Septal Defect Anatomies: An Expert-Based Review Authors: Bushra Shahida Rana, Brian Clapp, Iqbal Saeed Malik Published: 2026 ABSTRACT Transcatheter secundum atrial septal defect (ASD) closure is the preferred approach in the majority of cases. Building skill sets through understanding complex ASD anatomies is essential. Such anatomies include ASD associated with aneurysmal septum, multiple defects, absence of anterosuperior or posteroinferior rim and malaligned septum This expert-based review will focus on the key role of advanced TOE imaging during transcatheter ASD closure in challenging anatomies. We describe our institutional experience and provide a practical approach of how to plan and navigate device choice and its delivery to ensure optimal outcomes. 1. Introduction Transcatheter atrial septum defect (ASD) closure is the preferred approach in the majority of cases with secundum type ASD [1]. Avoiding cardiac surgery, sternotomy and cardiopulmonary bypass along with rapid recovery times and reduced in-hospital stay marks transcatheter atrial septum defect closure (tASDc) as the first-line standard treatment. Feasibility and procedure success depend on a number of factors including anatomical suitability (size and number of defects, rim stability and length), device size and characteristics (engineering concept of self-centering versus non-self-centering [2]), associated defects (where surgery may be more appropriate to address all pathologies), physiology (abnormal left or right ventricular compliance or pulmonary hypertension) and potential for complications. Appropriate case selection ensures complication rates of 1% or less [1]. Single secundum ASDs with firm adequately sized rims (≥5 mm) of moderate size or less (≤25 mm, comfortably within device range) are considered straightforward to close. Complex anatomies include ASD associated with aneurysmal septum (hypermobile floppy rims), multiple defects (including discrete or small multiple fenestrations), absence of anterosuperior or posteroinferior rim and malaligned septum (where there is septal tissue separation), for further explanation see Table 1. Device sizing and positioning present unique challenges with higher risk of device embolization, residual leaks and erosion. Our institutional experience with three-dimensional echocardiography (3DE) has significantly improved our ability to successfully treat complex anatomies. Awareness of the potential risk factors for complications improves device selection and decision making at the time of tASDc [3]. This expert-based review will focus on the key role of advanced TOE imaging during tASDc in challenging anatomies. We describe our institutional experience and provide a practical approach to each complex ASD phenotype. We include case illustrations performed by the authors. 2. Role of Advanced Transesophageal Echo Imaging Guidance Good knowledge of the principles of the procedure, recognition of complex morphologies, planning of device type and size, method of deployment and post-deployment checks are all essential steps [4]. Significant advances in echocardiography imaging and in particular 3DE has improved our understanding of complex morphologies [5,6,7]. 3DE allows an instantaneous appreciation of defect position, orientation, size and spatial relationships to surrounding structures. This comprehensive anatomical understanding provides insights into specific ASD characteristics and the interactions required for optimal device selection. Further, following device deployment, 3DE provides invaluable information superior to two dimensional (2D) imaging. The latest echo software permits seamless 3D multi-plane reconstruction (MPR) in real-time. This simplified method affords precise assessment of device conformity, alignment and correct capture of the rims. Thereby reducing both uncertainty and time required in determining a satisfactory deployment. Where deployment is suboptimal, 3DE can highlight crucial information not apparent with 2D imaging [8]. Therefore, experience in 3D transesophageal echocardiography (TOE) is essential. Table 2 summarizes our approach to optimal 3DE data acquisition. Correct image orientation enables precise dialogue between the interventionist and imager and is therefore encouraged. A systematic approach to assessment of the atrial septum (Figure 1) has previously been discussed elsewhere [9]. The assessment should include correctly orientated 3D en face views of the left and the right atrial septum (Figure 2). While used less frequently, other methods of echocardiographic imaging may be utilized (transthoracic echocardiography and intracardiac echocardiography) and are dependent on available resources, operator experience and patient cohort [10]. This article will focus on TOE, although the general principles described apply to all echocardiographic modalities. 3. Secundum ASD Complex Anatomies ASD with Absent Rim Incidences of device erosion are rare, 0.1–0.3% [11,12,13], and may present with chest pain, dyspnea, and hypotension due to hemopericardium, tamponade, aortic fistula and death [12]. Most erosions occur early after device deployment typically within 12 months. Although late erosions have been reported (as late as 8 years). Following initial reports, recommendations were made to mitigate the risks of erosion, highlighting echo predictors [14]. Most erosions occurred with deficient anterosuperior rim (aortic rim) and device oversizing. This rim deficiency being the most common. Therefore, the concept of balloon sizing using the colour Doppler ‘stop-flow’ method evolved [15]. Balloon sizing is not mandatory and will depend on the interventionist’s preference, along with the experience of the imager. 2DE using colour flow or 3DE (either direct from the 3D image or using MPR) measurements may also be utilized [16,17,18,19]. In our practice we do not routinely balloon size, we employ a simplified method either with 2D colour or 3D TOE to optimally device size—see Table 3 and Figure 3 for methods. When defect sizing doubt remains then balloon interrogation is the default (or may be the preferred method in all cases in some institutions), assessing not only defect size but rim behaviour and compliance. However, despite mitigating the risk of oversizing, careful consideration on optimal device type and its final positioning in relation to the atrial roof and aorta are crucial [5]. The TOE protocol should include a gradual sweep through the angles to critically assess the absence of an aortic/superior rim and its extent. 3DE imaging will depict the percentage of rim deficient, and whether this extends superiorly. Where no septum secundum tissue is seen, and the aortic wall exposed (termed ‘bald aorta’ [5]), then direct contact of an ASD device will occur. Contra-indications for complex ASD anatomies are summarized in Table 1. Routine procedural imaging steps have previously been described [9]. Specific imaging considerations for deficient aortic rim are highlighted in Figure 4. Assessment includes identification of aortic rim tissue (sufficient ≥ 5 mm, deficient < 5 mm or absent < 1 mm), its extension circumferentially around the aorta (best assessed using en face 3D view from the RA side) and whether the deficient rim extends superiorly to involve the atrial roof. In addition, it is important to ensure there is no malalignment of the septum primum attachments to the secundum septum (see section below). In our practice, device sizing can be performed using the methods described in Table 3 and Figure 3. A recognized challenge is seen during deployment where the device may continually prolapse from the LA into the RA, due to lack of sufficient aortic rim and angle of approach. Several additional steps may be attempted. The aim is to optimally align the delivery sheath so it is as coaxial as possible to the septum. This way when the LA disc of the device is exposed and brought back to the septum it catches the aorta without prolapsing into the RA. Such maneuvers include: rotation of the delivery sheath to point superior and posterior to allow better coaxial alignment with the septum; reshaping the sheath; device waist deployment in the LA to encourage LA disc to catch the aorta; right upper pulmonary vein technique to optimize delivery of the LA disc capture of the posterior-superior rim and prevent prolapse into the RA; and balloon assisted deployment where the balloon displaces the LA disc superiorly and posteriorly in the LA allowing better coaxial alignment of the device to the atrial septum [20,21], (Figure 5). During deployment the sheath should be imaged in its entirety (optimized by altering the image plane angle typically somewhere between 0 and 70 degrees) as it travels from the IVC across the RA and atrial septum into the LA. If the sheath position is difficult to locate then biplane imaging can be used to find the optimal view (independently altering the angle rotation of the right image to find the sheath in its entirety). Monitoring the device deployment and the relationship of the sheath and the LA disc to the atrial septum will help determine what steps are needed to enable a coaxial deployment of the LA disc, see Figure 5 and Table 4. The characteristics of the device appearance in relation to the aorta and atrial roof may help highlight high risk appearances necessitating device repositioning, resizing or perhaps even removal, see Figure 5 and Table 1 for contra-indications. These include the device discs pointing into and partially distorting the aorta, the device discs straddling the aorta but not tangentially aligned to the aorta, and dynamic cardiac motion with a device waist abutting the aorta and swaying in a see-saw motion. Other relevant rims include deficient superior and inferior-posterior rims. The former may result in direct device contact with the atrial roof. If accompanied by aortic root rim absence, it may be associated with increased risk of erosion. Early case reports noted absent superior rim to be a high-risk feature where the erosion occurred into the atrial roof on the RA side. Careful interrogation of the free walls of the LA and RA both superiorly (roof) as well as in the anterior and posterior regions is essential to ensure there is no disc contact. If the discs straddle the walls and are not directed into the wall (similar appearances to the aorta assessment) then it may be feasible to leave the device. Posterior and inferior rim deficiencies may be less easily imaged. If there is extensive rim deficiency involving most of the rim (>20% of circumference in our experience), tASDc may not be suitable due to significant risk of embolization. Advanced technique involving a combination of a covered stent placed at the orifice of the IVC (or SVC orifice in the case of absent SVC rim) and then deploying an ASD device has been described [22]. The inferior region can be difficult to visualize on TOE due to a small LA and a large RA. Further compounded by the close proximity of the inferior-posterior septum to the TOE probe. This can be overcome with retroflexion of the TOE probe. This increases the distance between the atrium and probe [23]. 3D imaging and MPR methods will give a comprehensive understanding of the extent of rim deficiency and rim length if present. Once the device is deployed, 2D with colour Doppler and 3D imaging, will allow step-by-step interrogation of the deficient rim and its relationship to the device. 3DE, including MPR, can provide on-axis imaging of device alignment to the surrounding structures and available space from both LA and RA views. This is invaluable in determining whether optimal deployment has been achieved and if any high-risk features exist (see Table 4). Such features include device protrusion into a wall, incomplete capture of septal tissue within the device discs and residual flow seen outside the device. Once the device is deployed, a similar 2D with colour and 3DE imaging protocol is performed to confirm a satisfactory final position. 4. ASD with Malaligned Septum Septal malalignment is a relatively infrequent finding during ASD closure. A precise definition is lacking and a variation in terms in the literature appear to describe similar entities including spiral, off-set and double layer atrial septum [24,25,26]. The unifying anatomical characteristic is malalignment or displacement of the septum primum (SP) towards the left atrial side, which is separated from the septum secundum (SS), (Figure 6). Risks arise when the defect is inappropriately sized due to the off-set nature of primum and secundum tissue. The degree of widest separation must be appreciated to ensure the device is correctly sized. In our experience if the separation is >8 mm then the discs will splay widely due to a broader waist as they negotiate this separation. This will result in a degree of ‘cotton reeling’ of the device. In this setting the device should be intentionally sized up 1 or 2 sizes depending on the degree of septum separation. When deploying the device care must be taken to ensure the LA disc has fully captured the SP tissue and resting fully within the LA. Similarly for the RA disc, this should rest fully in the thickened SS entirely within the RA. Risk of embolization typically occurs when one of the device discs is inadvertently placed within the space between the two layers of tissue, or the device has been wrongly sized. Careful 3DE assessment is essential to evaluate the position of both discs in their entirety using the en face LA and RA views. Further corroboration should be sought with 2D and colour Doppler assessment and then 3D MPR with a step-by-step 360 sweep rotating around the centre of the device viewing in detail both layers of tissue (SP and SS) positioned between the discs, see Figure 6 and Table 4. Some limited flow may be seen on colour Doppler particularly at the anterior rim, but as long as good coverage of the defect has been achieved by both discs and device stability confirmed then the device can be deployed. 5. Aneurysmal Septum ASD and Multiple Defects Transcatheter ASD closure in the presence of aneurysmal SP may increase the risk of device embolization. 3DE gives important insight into the overall size of the fossa ovalis (FO) and extent of hypermobile SP tissue as well as its attachments to SS, see Figure 7. It also depicts position and number of defects. Image resolution can at times be challenging when SP tissue is thin and mobile. The use of photorealistic imaging (Table 2) may circumvent this limitation. However, to accurately assess all defects 2D and 3D colour imaging is needed. Reducing the colour scale may improve defect identification. However, it may produce colour artefacts and confuse the assessment. Attempting image optimization by adjusting the gain, focus, reducing sector width and harmonic settings can improve image resolution. Use of multiple echo windows and reducing 3D zoom and 3D live sector acquisitions (increasing frame rates) will allow systematic septum interrogation to aid assessment, see Table 4. Where a single defect is found and, despite a hypermobile SP, the tissue attachments of the ASD are fixed without excessive motion, then standard echo measurements may suffice. In the case of hypermobile SP tissue involving the ASD margins, how much the ASD will fold back and open wider is unpredictable [27]. Wire passage through the defect gives important insight into any configuration change. Direct 3D dimension measurements can be repeated to re-assess if the defect appears larger. If doubt remains, then balloon sizing using the colour Doppler stop flow technique is necessary. For such complex defects it is our preference to balloon size. This gives us additional valuable information as to the compliance and behaviour of the defect and surrounding structures. In the case of multiple defects, attempts are made to cross the largest ASD. If multiple fenestrations then we aim for a central defect. The position and which defect has been crossed can be confirmed with 3DE imaging. Wire passage can be viewed from the RA side and followed across into the LA side. In the setting of a fenestrated hypermobile septum attempts should be made to cover the entire FO where possible—see Figure 8. This will ensure all defects identified or unidentified will be covered. In addition, the mobile septal tissue is captured allowing the device discs to rest on the secundum septum, providing stability. In such cases we measure the length of the septum in transverse and longitudinal planes (0 and 90). This can also be directly measured from the en face RA/LA 3DE views when the septum looks largest (ventricular systole). The typical ASD device has a large waist. Its diameter is the given device size. ASD closure concept is based on filling the defect with the waist of the device. Hence it is a self-centering device. In the case of very small defects (<5 mm) a non-self-centering device, such as Occlutech Uni (Occlutech UNI Occluder; Occlutech, Helsingborg, Sweden), Amplatzer Cribriform (Amplatzer Septal Occluder Cribriform; Abbott, St. Paul, MN, USA) or Gore Septal Occluder device (GSO, W.L. Gore & Associates, Newark, DE, USA) may be preferred if the disc sizes will cover the entire FO. For larger defects, individual balloon sizing is performed and, if appropriate (defects >7 mm apart, since the majority of self-centering ASD devices used have a LA disc size typically 7 mm wider than the waist), separate devices are attempted. Where the distance separating defects is <7 mm then balloon sizing with a degree of over stretching is considered. In this instance attempts are made to cover adjacent defects. If residual defects are left, then additional devices may be deployed. A general principle when using non-self-centering devices of any type is the disc size should be at least double the size of the defect crossed. Such devices may rest at one edge of the defect and unless the disc radius is at least 1–2 mm larger than the diameter of the defect there is a risk of a residual leak. The advantage being a larger percentage (if not all) of the FO will be covered. Prior to release, careful assessment of device mobility and its relationship to the aorta is essential to avoid the risk of complications. Device embolization may occur in this anatomy where one disc is inadvertently partially deployed on the same side as its counterpart. This is a risk associated with the hypermobile nature of the septum. Again, 3DE assessment is necessary to assess disc positioning in relation to the septal tissue, Table 4. 6. Very Large Secundum ASD In the setting of a very large ASD ≥ 30 mm, visualization of the defect in its entirety can be challenging. This is compounded by the relatively small LA size and, therefore, echo window sector width. Careful 2D and 3D systematic visualization of the ASD rims in sections will allow evaluation. Our practice is to use 3D live format to manually widen the sector widths in lateral and/or elevation planes with multi-beat acquisitions (to improve resolution) to visualize and assess step-by-step the entire atrial septum. Limitations in device closure include significant proportion of the deficient rim (continuously absent along 40% or more of the circumference in our experience, which equates to two adjacent rims being involved) and defect size being too large for the available devices [28]. The largest available balloon sizing diameter is 34 mm and, therefore, limits this technique for defect sizing [29]. When used the balloon may not form a clear waist, creating uncertainty as to where to measure the balloon diameter. If an attempt at closure is felt feasible, the widest diameter may be used to device size or an estimation taken from the entire septal length and, therefore, available space to determine device size. However, in most cases surgical closure is the preferred option. 7. Follow-Up and Device Surveillance Post tASDc imaging follow-up is essential when performing complex ASD closure. Potential complications can be assessed with transthoracic echocardiography (TTE). In cases of ‘bald’ aorta with deficient rim >20% (in our experience) or high-risk echo features more intense follow up may be preferred. Assessing device position and correct alignment with the atrial septum, residual abnormal flow (colour Doppler flow around and outside the device) and presence of pericardial effusion may be early warning signs of device complications. Typical practice includes a TTE immediately post procedure, followed by 4–6 weeks check to ensure device position and absence of other complications. Then a further comprehensive assessment at 6–12 months which should include right heart size, function and pulmonary pressure measurements [3]. In select cases with potential high-risk echo features, additional assessment may be needed at 1 week, 1 month, 6 and 12 months and, if concerns remain, annually thereafter [30]. Ideally prior to device closure, in the presence of complex anatomy, the pros and cons should be discussed with the patient. Post procedure (as would be the case in all patients), careful counselling of concerning symptoms (chest pain, syncope, fevers) and importance of early or urgent review should be emphasized. 8. Conclusions Transcatheter closure is the preferred approach in the majority of secundum atrial septal defects. Advanced echocardiography, and in particular 3D imaging, is pivotal in understanding ASD morphology. Complex anatomies encountered include deficient rim, malaligned septum, multiple defects and aneurysmal atrial septum. 3D echo formats (biplane imaging, live 3DE and MPR mode) provide a comprehensive assessment of the entire defect, its surrounding anatomy and allow precise planning of device type, device size and method of deployment. Careful assessment using 3DE of the device prior to and post-release can be performed with confidence and may reduce the risk of device embolization, residual leaks and erosion. As transcatheter therapies continue to evolve and complex anatomies increasingly treated, advanced echo techniques are proving to be an essential tool to their success.